387 related articles for article (PubMed ID: 25675297)
1. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
[TBL] [Abstract][Full Text] [Related]
2. Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation.
Sakai I; Miyake H; Fujisawa M
BJU Int; 2013 Jul; 112(2):E211-20. PubMed ID: 23305097
[TBL] [Abstract][Full Text] [Related]
3. N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation.
Liu J; Liu H; Zhang W; Wu Q; Liu W; Liu Y; Pan D; Xu J; Gu J
Glycobiology; 2013 Sep; 23(9):1097-109. PubMed ID: 23811795
[TBL] [Abstract][Full Text] [Related]
4. Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma.
Chen L; Liu H; Liu J; Zhu Y; Xu L; He H; Zhang H; Wang S; Wu Q; Liu W; Liu Y; Pan D; Ren S; Xu J; Gu J
PLoS One; 2013; 8(3):e58413. PubMed ID: 23516476
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells.
Zhu Y; Xu L; Zhang J; Hu X; Liu Y; Yin H; Lv T; Zhang H; Liu L; An H; Liu H; Xu J; Lin Z
Cancer Sci; 2013 Aug; 104(8):1052-61. PubMed ID: 23578198
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism mediating cytotoxic activity of axitinib in sunitinib-resistant human renal cell carcinoma cells.
Miyazaki A; Miyake H; Fujisawa M
Clin Transl Oncol; 2016 Sep; 18(9):893-900. PubMed ID: 26597115
[TBL] [Abstract][Full Text] [Related]
7. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
8. Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathways.
Gobe GC; Ng KL; Small DM; Vesey DA; Johnson DW; Samaratunga H; Oliver K; Wood S; Barclay JL; Rajandram R; Li L; Morais C
Biochem Biophys Res Commun; 2016 Apr; 473(1):47-53. PubMed ID: 26995091
[TBL] [Abstract][Full Text] [Related]
9. The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma.
Makhov P; Naito S; Haifler M; Kutikov A; Boumber Y; Uzzo RG; Kolenko VM
Cell Death Dis; 2018 Mar; 9(3):374. PubMed ID: 29515108
[TBL] [Abstract][Full Text] [Related]
10. Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma.
O'Sullivan GC; Tangney M; Casey G; Ambrose M; Houston A; Barry OP
Int J Cancer; 2007 Nov; 121(9):1930-1940. PubMed ID: 17621631
[TBL] [Abstract][Full Text] [Related]
11. NGAL can alternately mediate sunitinib resistance in renal cell carcinoma.
Yu DS; Wu CL; Ping SY; Huang YL; Shen KH
J Urol; 2014 Aug; 192(2):559-66. PubMed ID: 24423438
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function.
Maita S; Yuasa T; Tsuchiya N; Mitobe Y; Narita S; Horikawa Y; Hatake K; Fukui I; Kimura S; Maekawa T; Habuchi T
Int J Cancer; 2012 Feb; 130(3):677-84. PubMed ID: 21387300
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PAK1 alleviates cerulein-induced acute pancreatitis via p38 and NF-κB pathways.
Zhu M; Xu Y; Zhang W; Gu T; Wang D
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30718368
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1.
Liu F; Li X; Wang C; Cai X; Du Z; Xu H; Li F
Int J Cancer; 2009 Dec; 125(11):2511-9. PubMed ID: 19610058
[TBL] [Abstract][Full Text] [Related]
15. Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines.
Mizumoto A; Yamamoto K; Nakayama Y; Takara K; Nakagawa T; Hirano T; Hirai M
J Pharmacol Exp Ther; 2015 Nov; 355(2):152-8. PubMed ID: 26306766
[TBL] [Abstract][Full Text] [Related]
16. Adrenomedullin blockade suppresses sunitinib-resistant renal cell carcinoma growth by targeting the ERK/MAPK pathway.
Gao Y; Li J; Qiao N; Meng Q; Zhang M; Wang X; Jia J; Yang S; Qu C; Li W; Wang D
Oncotarget; 2016 Sep; 7(39):63374-63387. PubMed ID: 27556517
[TBL] [Abstract][Full Text] [Related]
17. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
Oka D; Nishimura K; Shiba M; Nakai Y; Arai Y; Nakayama M; Takayama H; Inoue H; Okuyama A; Nonomura N
Int J Cancer; 2007 Jun; 120(12):2576-81. PubMed ID: 17290398
[TBL] [Abstract][Full Text] [Related]
18. Identification of TGF-β-activated kinase 1 as a possible novel target for renal cell carcinoma intervention.
Meng F; Li Y; Tian X; Fu L; Yin Y; Sui C; Ma P; Jiang Y
Biochem Biophys Res Commun; 2014 Oct; 453(1):106-11. PubMed ID: 25261726
[TBL] [Abstract][Full Text] [Related]
19. Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma.
Su SC; Hu X; Kenney PA; Merrill MM; Babaian KN; Zhang XY; Maity T; Yang SF; Lin X; Wood CG
Clin Cancer Res; 2013 Dec; 19(23):6461-72. PubMed ID: 24122794
[TBL] [Abstract][Full Text] [Related]
20. PRKX, TTBK2 and RSK4 expression causes Sunitinib resistance in kidney carcinoma- and melanoma-cell lines.
Bender C; Ullrich A
Int J Cancer; 2012 Jul; 131(2):E45-55. PubMed ID: 22020623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
